Acrivon awards CBO 130K options, 30K RSUs
Acrivon Therapeutics’ chief business officer received new stock options and restricted stock units that vest over time, increasing her equity-based compensation exposure.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Acrivon Therapeutics, Inc. (ACRV) reported that Chief Business Officer Michaela Levin received equity-based compensation on August 31, 2026. She was granted 130,000 options to buy common stock at an exercise price of $2.09 per share, expiring August 30, 2036, and 30,000 restricted stock units
Insider Trade Summary
Grant/Award: 160,000 shares
Grant/Award
2 txns
Insider
Levin Michaela
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 130,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 130,000 contracts (Direct);
Common Stock — 30,000 shares (Direct)
Footnotes (2)
- F1. These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in full on September 1, 2027, subject to the Reporting Person's continuous service through such vesting date.
- F2. Twenty-five percent (25%) of the shares subject to the option vest on September 1, 2027, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.
Key Figures
Stock options granted: 130,000 options
Option exercise price: $2.09 per share
Option expiration date: August 30, 2036
+5 more
8 metrics
Stock options granted
130,000 options
Options to purchase Acrivon common stock granted on August 31, 2026
Option exercise price
$2.09 per share
Exercise price for the 130,000 stock options granted to Michaela Levin
Option expiration date
August 30, 2036
Expiration of the 130,000 stock options if not earlier exercised or forfeited
Restricted stock units granted
30,000 RSUs
Restricted stock units representing contingent rights to Acrivon common stock
RSU vesting date
September 1, 2027
Date on which all 30,000 restricted stock units vest, subject to continuous service
Initial option vesting percentage
25%
Portion of option shares that vest on September 1, 2027
Remaining option vesting period
36 monthly installments
Remaining option shares vest in substantially equal monthly installments after initial vesting
Common shares held after RSU grant
30,000 shares
Direct common stock position reported after the RSU grant
Key Terms
restricted stock units ("RSUs"), contingent right, continuous service, vesting date
4 terms
restricted stock units ("RSUs") financial
"These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date."
vesting date financial
"continuous service through such vesting date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ACRV grant to Chief Business Officer Michaela Levin?
Michaela Levin received 130,000 stock options with an exercise price of $2.09 per share and 30,000 restricted stock units, all as direct holdings, on August 31, 2026.
When do Michaela Levin’s new ACRV restricted stock units vest?
The 30,000 restricted stock units granted to Michaela Levin vest in full on September 1, 2027, subject to her continuous service through that vesting date.
What is the vesting schedule for Michaela Levin’s new ACRV stock options?
For the 130,000 stock options, 25% vest on September 1, 2027. The remaining shares vest in 36 substantially equal monthly installments, subject to her continuous service through each vesting date.
What is the exercise price and expiration date of Michaela Levin’s ACRV stock options?
The newly granted stock options to Michaela Levin have an exercise price of $2.09 per share and expire on August 30, 2036, if not earlier exercised or forfeited.
Were Michaela Levin’s ACRV equity awards made under a Rule 10b5-1 trading plan?
No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with these equity awards to Michaela Levin.
AI-generated analysis. How Rhea-AI works. Not financial advice.
